Abstract:Background and objectives: Observational study has found inflammatory bowel disease to be associated with multiple extraintestinal manifestations. To this end, we characterized the causal association between inflammatory bowel disease and extraintestinal manifestations through a Mendelian randomization study and further explored the role of intestinal flora in inflammatory bowel disease and the extraintestinal manifestations associated with it. Materials and methods: We genetically predicted the causal relationship between inflammatory bowel disease and twenty IBD-related extraintestinal manifestations (including sarcoidosis, iridocyclitis, interstitial lung disease, atopic dermatitis, ankylosing spondylitis, psoriatic arthropathies, primary sclerosing cholangitis, primary biliary cholangitis). We used the full genome-wide association study (GWAS) summary statistics on gut microbiota in 18,340 participants from 24 cohorts to explore its role in the casual relationships between IBD and IBD-related extraintestinal manifestations. Inverse variance weighting (IVW) was used as the main analytical method to assess the causal associations. We performed Cochran's Q test to examine the heterogeneity. To assess the robustness of the IVW results, we further performed sensitivity analyses including the weighted median method, MR-Egger regression, and Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO) test. The leave-one-out sensitivity analysis was further performed to monitor if significant associations were dominated by a single nucleotide polymorphism (SNP). Result: A total of eight extraintestinal manifestations were found to be at elevated risk of development due to inflammatory bowel diseases. A total of 11 causal relationships were found between IBD and gut microbiota, four of which were stable. Between gut microbiota and these eight extraintestinal manifestations, a total of 67 nominal causal associations were identified, of which 13 associations were stable, and notably 4 associations were strongly correlated. Conclusion: Through the two-sample MR analysis, we identified extraintestinal manifestations that were causally associated with inflammatory bowel disease and obtained multiple associations from inflammatory bowel disease and gut microbiota, and gut microbiota and extraintestinal manifestations in further analyses. These associations may provide useful biomarkers and potential targets for pathogenesis and treatment.

Associations of inflammatory cytokines with inflammatory bowel disease: a Mendelian randomization study

Interleukin-17 and Inflammatory Bowel Disease: a 2-Sample Mendelian Randomization Study

Assessment of the causal relationship between inflammatory bowel diseases and chronic kidney diseases: A two-sample bidirectional mendelian randomization study among European population

Mendelian Randomization As an Approach to Assess Causal Effects of Inflammatory Bowel Disease on Atrial Fibrillation.

Causal Linkage Between Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Two-Sample Mendelian Randomization Analysis

Association between inflammatory bowel disease and interleukins, chemokines: a two-sample bidirectional mendelian randomization study

Causal role of immune cells in inflammatory bowel disease: A Mendelian randomization study

Causal relationship between circulating immune cells and inflammatory bowel disease: A Mendelian randomization analysis

Does Chronic Intestinal Inflammation Promote Atrial Fibrillation: A Mendelian Randomization Study with Populations of European Ancestry.

Causal association of blood cell traits with inflammatory bowel diseases: a Mendelian randomization study

Mendelian Randomization Study for the Roles of IL-18 and IL-1 Receptor Antagonist in the Development of Inflammatory Bowel Disease.

The gut-lung axis: Mendelian randomization identifies a causal association between inflammatory bowel disease and interstitial lung disease

The Role of Inflammatory Biomarkers in Mediating the Effect of Inflammatory Bowel Disease on nonmalignant Digestive System Diseases: A Multivariable Mendelian Randomized Study

Associations between sex hormones, receptors, binding proteins and inflammatory bowel disease: a Mendelian randomization study

Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: A Mendelian randomization

Causal association between inflammatory bowel disease and IgA nephropathy: A bidirectional two-sample Mendelian randomization study

Gut microbiota does not play a mediating role in the causal association between inflammatory bowel disease and several its associated extraintestinal manifestations: a Mendelian randomization study

IDDF2023-ABS-0105 Causal relationships between immunological proteins and common intestinal diseases: a bidirectional two-sample mendelian randomization study

The immune factors have complex causal regulation effects on inflammatory bowel disease

Evaluating the Causal Association Between Inflammatory Bowel Disease and Risk of Atherosclerotic Cardiovascular Disease: Univariable and Multivariable Mendelian Randomization Study.

Genetic association of circulating interleukins and risk of colorectal cancer: A bidirectional Mendelian randomization study